{"title":"Identification of subtypes of type 2 diabetes in the Chinese population and their distinct complication risk profiles.","authors":"Qiu Xiao, Chengjun Zhang, Yanfeng Jiang, Chen Suo, Genming Zhao, Xingdong Chen, Min Chen, Kelin Xu","doi":"10.1111/dom.70056","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To identify and validate subgroups of type 2 diabetes in Chinese populations using clustering analysis and assess their complication risks.</p><p><strong>Materials and methods: </strong>Data from 5653 type 2 diabetes patients in the Shanghai Suburban Adult Cohort and Biobank (SSACB) and 6384 in the Southwest China Diabetic Chronic Complications Study were integrated. Using body mass index, fasting blood glucose, age at diabetes diagnosis, and triglycerides to high-density lipoprotein cholesterol ratio, k-means clustering was performed by sex in SSACB and validated in Southwest China Diabetic Chronic Complications Study. Cox and logistic regression models compared complication risks.</p><p><strong>Results: </strong>Five type 2 diabetes subgroups were identified: Hyperglycaemic Diabetes (HGD), Obesity-Related Diabetes (ORD), Young-Onset Diabetes (YOD), Insulin Resistance Diabetes (IRD), and Elderly-Onset Diabetes (EOD). Verification in an external validation cohort confirmed the robustness and reproducibility of the identified subgroups. In SSACB, distinct subgroup-specific complication risks were observed. Specifically, the HGD subgroup showed the highest risks for stroke (HR = 1.37, 95% CI: 1.10-1.70), peripheral vascular disease (HR = 1.66, 95% CI: 1.36-2.03), retinopathy (HR = 3.53, 95% CI: 2.53-4.90), peripheral neuropathy (HR = 1.89, 95% CI: 1.56-2.30), and nephropathy (HR = 1.81, 95% CI: 1.41-2.34). The IRD subgroup had the highest risk for coronary heart disease (HR = 1.20, 95% CI: 1.01-1.43). Similar risk patterns were observed in the validation cohort.</p><p><strong>Conclusions: </strong>We identified five clinically distinct type 2 diabetes subgroups with differential complication risks in the Chinese population, providing a basis for precision diabetes management.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.70056","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: To identify and validate subgroups of type 2 diabetes in Chinese populations using clustering analysis and assess their complication risks.
Materials and methods: Data from 5653 type 2 diabetes patients in the Shanghai Suburban Adult Cohort and Biobank (SSACB) and 6384 in the Southwest China Diabetic Chronic Complications Study were integrated. Using body mass index, fasting blood glucose, age at diabetes diagnosis, and triglycerides to high-density lipoprotein cholesterol ratio, k-means clustering was performed by sex in SSACB and validated in Southwest China Diabetic Chronic Complications Study. Cox and logistic regression models compared complication risks.
Results: Five type 2 diabetes subgroups were identified: Hyperglycaemic Diabetes (HGD), Obesity-Related Diabetes (ORD), Young-Onset Diabetes (YOD), Insulin Resistance Diabetes (IRD), and Elderly-Onset Diabetes (EOD). Verification in an external validation cohort confirmed the robustness and reproducibility of the identified subgroups. In SSACB, distinct subgroup-specific complication risks were observed. Specifically, the HGD subgroup showed the highest risks for stroke (HR = 1.37, 95% CI: 1.10-1.70), peripheral vascular disease (HR = 1.66, 95% CI: 1.36-2.03), retinopathy (HR = 3.53, 95% CI: 2.53-4.90), peripheral neuropathy (HR = 1.89, 95% CI: 1.56-2.30), and nephropathy (HR = 1.81, 95% CI: 1.41-2.34). The IRD subgroup had the highest risk for coronary heart disease (HR = 1.20, 95% CI: 1.01-1.43). Similar risk patterns were observed in the validation cohort.
Conclusions: We identified five clinically distinct type 2 diabetes subgroups with differential complication risks in the Chinese population, providing a basis for precision diabetes management.
期刊介绍:
Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.